#Oncology Breakthrough

Explore our comprehensive coverage of oncology breakthrough, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

1Articles

1Authors

4Total Views

Landmark RASolute-302 Trial Doubles Survival in Metastatic Pancreatic Cancer with Daraxonrasib

Featured

By Katherine Anne WhitfieldJul 17, 2026

Landmark RASolute-302 Trial Doubles Survival in Metastatic Pancreatic Cancer with Daraxonrasib

The pivotal RASolute-302 phase 3 clinical trial has revealed that daraxonrasib, a multi-selective RAS(ON) inhibitor, nearly doubles overall survival i...

Read Full Story →

#Oncology Breakthrough

Landmark RASolute-302 Trial Doubles Survival in Metastatic Pancreatic Cancer with Daraxonrasib

Recent Articles